Skip to main content

Want a detailed portfolio tracker?

Biohaven (BHVN) P/E (2022 - 2026)

Biohaven (BHVN) P/E from Sep 23, 2022 to Jul 21, 2026. The TTM Biohaven (BHVN) P/E is -2.83. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Biohaven (BHVN)

YearP/EChange
2026-2.83+69.98%
2025-1.67-59.02%
2024-4.06-35.39%
2023-6.29+308.14%
2022-1.54N/A

Comparison Biohaven (BHVN) P/E with competitors

Biohaven (BHVN) P/E is -2.83.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.06%
NBYStablecoin Development Corp0.00-100.15%
ENLVEnlivex Ltd0.07-102.64%
FGENFibroGen Inc0.24-108.48%
CHRSCoherus Biosciences Inc0.85-129.98%
FBIOFortress Biotech Inc0.95-133.53%
ORMPOramed Pharmaceuticals Inc1.50-153.10%
AGENAgenus Inc3.01-206.32%
INVAInnoviva Inc3.15-211.42%
VXRTVaxart Inc3.55-225.40%
CRMDCorMedix Inc3.63-228.18%
CVACCureVac N.V.4.45-257.05%
GLPGGalapagos NV4.86-271.65%
SRPTSarepta Therapeutics Inc4.88-272.47%
ABEOAbeona Therapeutics Inc5.39-290.33%
ABUSArbutus Biopharma Corp5.60-297.68%
ZVRAZevra Therapeutics Inc5.89-307.98%
SPROSpero Therapeutics Inc6.23-320.03%
CGENCompugen Ltd6.31-323.05%
RIGLRigel Pharmaceuticals6.87-342.77%
SLXNSilexion Therapeutics Corp7.30-357.75%
OMEROmeros Corporation9.26-427.09%
AUPHAurinia Pharmaceuticals Inc9.58-438.61%
PLXProtalix BioTherapeutics Inc10.89-484.75%
ACADAcadia Pharmaceuticals Inc11.73-514.34%
TBPHTheravance Biopharma Inc12.26-533.19%
ADMAAdma Biologics Inc12.42-538.70%
HRMYHarmony Biosciences Holdings Inc13.82-588.23%
SABSSAB Biotherapeutics Inc14.14-599.39%
NAGENiagen Bioscience Inc14.82-623.49%
INCYIncyte Corp15.82-658.97%
REGNRegeneron Pharmaceuticals Inc15.86-660.17%
PBYIPuma Biotechnology Inc17.32-711.72%
CPRXCatalyst Pharmaceuticals Inc17.44-716.08%
EXELExelixis Inc17.54-719.57%
TGTXTG Therapeutics Inc18.97-770.02%
MDXGMimedx Group Inc20.55-826.07%
XOMAXOMA Royalty Corp22.87-908.12%
ARGXArgen X SE24.30-958.41%
CTMXCytomX Therapeutics Inc24.82-976.89%
XOMAOXOMA Royalty Corp25.34-995.39%
HALOHalozyme Therapeutics Inc25.62-1005.24%
XOMAPXOMA Royalty Corp25.67-1006.88%
VRTXVertex Pharmaceuticals Inc27.99-1089.01%
RPRXRoyalty Pharma plc - Class A28.69-1113.48%
SLNOSoleno Therapeutics Inc29.02-1125.06%
ASNDAscendis Pharma A/S30.09-1162.87%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1439.37%
APLSApellis Pharmaceuticals Inc39.02-1478.55%
BMRNBiomarin Pharmaceutical Inc42.21-1591.27%
KRYSKrystal Biotech Inc45.34-1701.91%
ONCBeiGene Ltd69.54-2556.75%
PHARPharming Group N.V.75.03-2750.53%
TECHBio-Techne Corp101.96-3702.02%
VCELVericel Corp109.92-3983.34%
ALNYAlnylam Pharmaceuticals Inc117.96-4267.51%
GMABGenmab140.29-5056.24%
TLXTelix Pharmaceuticals Ltd162.15-5828.59%
CORTCorcept Therapeutics Inc212.86-7619.90%